Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients

OBJECTIVE: The study aimed to investigate the over expression of IFITM3 in hepatocellular carcinoma Egyptian patients. BACKGROUND: Hepatocellular carcinoma (HCC) continues to be a serious disease burden. Interferon Induced Transmembrane protein 3 (IFITM3) is a protein that encoded in humans by the I...

Descripción completa

Detalles Bibliográficos
Autores principales: Bondok, Rania M., Barakat, Lamiaa A., Elsergany, Alyaa R., Mahsoub, Nancy, Ghattas, Maivel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290370/
https://www.ncbi.nlm.nih.gov/pubmed/37353775
http://dx.doi.org/10.1186/s12885-023-11071-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290370/
https://www.ncbi.nlm.nih.gov/pubmed/37353775
http://dx.doi.org/10.1186/s12885-023-11071-2

Ejemplares similares